Skip to main content

$0.250 0.010 (4.17%)

High

$0.25

Low

$0.24

Trades

8

Turnover

$2,856

Volume

11,676
30 June 2023 at 3:47pm
Register to track VTI and receive email alerts.
Subject
VTI Ann: Director Appointment and Retirement

VTI Ann: Notice given under Section 708A(5)(e) of Corporations Act

VTI Ann: Application for quotation of securities - VTI

VTI Ann: Notification regarding unquoted securities - VTI

VTI Ann: Notification of cessation of securities - VTI

VTI Ann: Notice of change of interests of substantial holder

VTI Ann: Change in substantial holding

VTI Ann: Results of Annual Meeting of Stockholders

VTI Ann: Adjournment of Annual Meeting of Stockholders

VTI Ann: Investor Presentation

VTI Ann: Notice of Annual Meeting of Stockholders

VTI Ann: Appendix 4G & Corporate Governance Statement

VTI Ann: 2021 Annual Report

VTI Ann: Investor Presentation

VTI Ann: Appendix 4C and Business Activity Report - March-22 Qtr

VTI Ann: Notification of cessation of securities - VTI

VTI Ann: Notification regarding unquoted securities - VTI

VTI Ann: Notification of cessation of securities - VTI

VTI Ann: Change of Director's Interest Notice - David Mazzo

VTI Ann: Notice given under Section 708A(5)(e) of Corporations Act

VTI Ann: Application for quotation of securities - VTI

VTI Ann: Appendix 4E and Annual Financial Statements

VTI Ann: Investor Presentation

VTI Ann: Appendix 4C and Business Activity Report - Dec-21 Qtr

VTI Ann: VTI Announces Initiation of the PROTECT Clinical Trial

VTI Ann: Notification of cessation of securities - VTI

VTI Ann: Final Director's Interest Notice - Dr Stephen Snowdy

VTI Ann: Notification regarding unquoted securities - VTI

VTI Ann: VTI Announces the Departure of CEO Stephen Snowy, PhD

VTI Ann: Notice of Initial Substantial Holder

VTI Ann: Ceasing to be a substantial holder

VTI Ann: VTI Unveils New NaturalVue Enhanced Multifocal

VTI Ann: Appointment of Ashley Tuan, OD, PhD as CMO

VTI Ann: 6-year Myopia Progression Data for NaturalVue Multifocal

VTI Ann: Appendix 4C and Business Activity Report - Sep-21 Qtr

VTI Ann: Notification regarding unquoted securities - VTI

VTI Ann: US Patent Office Allows Key Patent for VTI

VTI Ann: Appendix 4D & Financial Statements 30 June 2021

VTI Ann: VTI to present - Coffee Microcaps Appendix 4C Reporting Wrap

VTI Ann: Investor Presentation

VTI Ann: Visioneering Expands Portfolio with Adelaides Innovatus

VTI Ann: VTI to present at Spark Plus's Healthcare Day 27 July 2021

VTI Ann: Quarterly Business Activity Report and Appendix 4C

VTI Ann: Notification of cessation of securities - VTI

VTI Ann: Initial Director's Interest Notice - Dr Dwight Akerman

VTI Ann: Director Appointment

VTI Ann: Reverse Stock Split and Dispatch of Holding Statements

VTI Ann: Retirement of Director

VTI Ann: Results of Meeting

VTI Ann: Update - Consolidation/Split - VTI

Register to track VTI and receive email alerts.